SEC Form SC 13G/A filed by Oncorus Inc. (Amendment)

(b)	Address of Issuer's Principal Executive Offices:

Item 2. (a)

Name of Person Filing:

(b)

Address of Principal Business Office:

(c)

Citizenship or Place of Incorporation:

(d)

Title of Class of Securities:

(e)

CUSIP Number:

Item 3.

Not applicable.

Item 4.

Ownership:

(a)

Amount beneficially owned:

•

1,067,093 shares of Common Stock, representing a total of 4.11% of the total shares of Common Stock outstanding, are held directly by Arkin Bio Ventures Limited Partnership.

•

1,441,388shares of Common Stock, representing a total of 5.55% of the total shares of Common Stock outstanding, are held by Mr. Moshe Arkin through his individual retirement account.

(b)

Percent of class:

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote:

(ii)

Shared power to vote or to direct the vote:

(iii)

Sole power to dispose or to direct the disposition of:

(iv)

Shared power to dispose or to direct the disposition of:

Item 5.

Ownership of Five Percent or Less of a Class:

Item 6.

Ownership of More than Five Percent on Behalf of Another:

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Item 8.

Identification and Classification of Members of the Group:

Item 9.

Notice of Dissolution of Group: